Non Alcoholic Fatty Liver Disease: Nutrition & NAFLD, Dr. Shira Zelber-Sagi
Abstract: Inter-genotypic recombinant HCV virus (the mutant "Ninja" virus): prevalence and clinical implication, R. Daniel, M. Barak, O. Azulay, E. Zuckerman
Abstract: The Natural History of Ultrasound diagnosed nonalcoholic fatty liver disease (NAFLD) in Hadassah: Long-term mortality, N. Natour et al.
Abstract: Monitoring the effect of large volume paracenthesis on systemic hemodynamic parameters using the Non-Invasive Cardiac (NICAS) system. A pilot study, Berdichevski T. et al.
NAFLD, pre-atherogenic lesions and cardiovascular events, Prof. Sven Francque M.A
Abstract: Fibro scan and Cognitive Dysfunction in Obese Individuals with (MAO) ot without (MHO) Metabolic Risk Factors, Abo Saleh A, Grosovski M, Bar Guy N and Assy N.
Abstract: Sortilin affects ductular reaction and bile duct morphogenesis in cholestatic liver injury, E. Huble-Manor, I. Zvibel, O. Shibolet
Abstract: Hepatitis E in Israel: A nation-wide retrospective study, from a non-endemic country, Erez O. et al.
Current and Future Therapy for NASH, Prof. Ran Oren
Myths of the INR in Liver disease - The INR does not predict bleeding and its correction is not beneficial, Prof Adrian Reuben
Challenges on Living Related Liver Transplantation, Prof. Yaman Tokat
Abstract: Resistance mutations to inhibitors targeting the HCV genotype 1 NS3/4A, NS5B and NS5A proteins in Israel, Z. Ben Ari et al.
Abstract: Accuracy of Real-Time Shear Wave Elastography for Assessing Liver Fibrosis in Hepatitis C and non HCV Chronic Liver Disease- Histological correlation in more than 80 patients, Cohen-Ezra O. et al.
Abstract: Morphometry accurately define Liver Fibrosis Grade at an early stages of Fibrosis, N. Higazi et al.
Abstract: HCV fibrosis progression in Hadassah by Re Biopsies: Suggestion how to monitor low fibrotics, S. Yaari et al.
Abstract: Characterization of Nonalcoholic Fatty Liver Disease in large Cohort of more than 11000 diagnosed Patients in Israel, Netanel C., Abel R., Shevy M., Ben-Ari Z.
The Israeli real life HCV interferon free, Prof. Eli Zuckerman
Classic & Future Anticoagulation therapy in cirrhotic patients, Prof. Gili Kenet
Primary prophylaxis of esophageal varices in Cirrhosis- past, present and future, Dr. Eyal Ashkenazi
Abstract: Pioglitazone hydrochloride prevents NK cell insulin resistance and enhances their activity in Nonalcoholic Fatty Liver Disease patients via mTOR pathway, J. Amer, A. Salhab, R. Safadi
Abstract: The use of Selective Internal Radiation Therapy (SIRT) in Hepatocellular Carcinoma - A single center experience, I. Bar-Yishay, L. Mlynarsky, Y. Menachem, O. Shibolet
Abstract: The chemokine receptor CCR2 and Interleukin 23 derived from antigen presenting cells are essential for primary biliary cirrhosis progression, D. Reuveny et al.
Abstract: Monocytes regulate neutrophil activity and clearance in a model of drug-induced liver injury, N. Graubardt et al.